PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.41%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$147M
AUM Growth
+$147M
(-65%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-192.45%
Top 10 Holdings %
Top 10 Hldgs %
70.47%
Holding
63
New
13
Increased
6
Reduced
9
Closed
9
Top Buys
| 1 |
Exact Sciences
EXAS
|
$33.3M |
| 2 |
Intuitive Surgical
ISRG
|
$9.6M |
| 3 |
Glaukos
GKOS
|
$7.45M |
| 4 |
Metagenomi
MGX
|
$4.87M |
| 5 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
$4.02M |
Top Sells
| 1 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
$328M |
| 2 |
Establishment Labs
ESTA
|
$7.96M |
| 3 |
Quanterix
QTRX
|
$6.49M |
| 4 |
Avita Medical
RCEL
|
$5.23M |
| 5 |
Insulet
PODD
|
$2.71M |
Sector Composition
| 1 | Healthcare | 95.98% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exact Sciences
EXAS
$8.98B
| $33.3M | 5.61% | +481,910 | New | +$33.3M |
|
|
2
Establishment Labs
ESTA
$1.2B
| $13.3M | 2.25% | 261,673 -156,321 | -37% | -$7.96M |
|
|
3
Intuitive Surgical
ISRG
$170B
| $9.6M | 1.62% | +24,050 | New | +$9.6M |
|
|
4
Quanterix
QTRX
$211M
| $8.86M | 1.49% | 375,985 -275,347 | -42% | -$6.49M |
|
5
Lyra Therapeutics
LYRA
$11.5M
| $8.79M | 1.48% | 1,413,242 | – | – |
|
|
6
Glaukos
GKOS
$5.5B
| $7.45M | 1.26% | +79,000 | New | +$7.45M |
|
7
Natera
NTRA
$23.1B
| $6.55M | 1.1% | 71,606 -21,394 | -23% | -$1.96M |
|
|
8
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $5.81M | 0.98% | 580,000 +401,691 | +225% | +$4.02M |
|
9
LivaNova
LIVN
$3.08B
| $5.04M | 0.85% | 90,151 -39,849 | -31% | -$2.23M |
|
|
10
Metagenomi
MGX
$65.3M
| $4.87M | 0.82% | +461,283 | New | +$4.87M |
|
11
Alphatec Holdings
ATEC
$2.35B
| $4.41M | 0.74% | 320,054 +15,054 | +5% | +$208K |
|
12
Pulmonx
LUNG
$69.7M
| $4.33M | 0.73% | 466,787 -10,611 | -2% | -$98.4K |
|
13
DexCom
DXCM
$29.5B
| $4.16M | 0.7% | 30,000 +3,843 | +15% | +$533K |
|
14
Viking Therapeutics
VKTX
$3.04B
| $3.27M | 0.55% | +39,868 | New | +$3.27M |
|
15
Inspire Medical Systems
INSP
$2.77B
| $3.22M | 0.54% | 15,000 +5,000 | +50% | +$1.07M |
|
16
Elanco Animal Health
ELAN
$9.12B
| $3.15M | 0.53% | 193,250 -36,750 | -16% | -$598K |
|
|
SWAV
17
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.86M | 0.48% | +8,771 | New | +$2.86M |
|
18
Repligen
RGEN
$6.88B
| $2.06M | 0.35% | +11,225 | New | +$2.06M |
|
19
Guardant Health
GH
$8.41B
| $2.06M | 0.35% | 100,000 +85,000 | +567% | +$1.75M |
|
|
CUTR
20
DELISTED
Cutera, Inc.
CUTR
| $1.59M | 0.27% | 1,078,727 +8,233 | +0.8% | +$12.1K |
|
|
IMDX
21
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $1.54M | 0.26% | 523,928 -63,002 | -11% | -$185K |
|
22
Tandem Diabetes Care
TNDM
$845M
| $1.5M | 0.25% | +42,500 | New | +$1.5M |
|
23
Edwards Lifesciences
EW
$47.8B
| $1.47M | 0.25% | +15,408 | New | +$1.47M |
|
24
10x Genomics
TXG
$1.74B
| $1.43M | 0.24% | +38,005 | New | +$1.43M |
|
25
Baxter International
BAX
$12.7B
| $1.28M | 0.22% | +30,000 | New | +$1.28M |
|